The expression of hepatocyte growth factor (HGF) and c-Met in uterine serous carcinoma (Q82941868)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21168200%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

The expression of hepatocyte growth factor (HGF) and c-Met in uterine serous carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21168200%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Uterine serous carcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21168200%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Erin A Bishop

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21168200%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

S Diane Yamada

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21168200%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Anthony Montag

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21168200%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Sarah M Temkin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21168200%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

17 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21168200%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21168200%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21168200%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21168200%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

218-223

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21168200%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

The use of P53, PTEN, and C-erbB-2 to differentiate uterine serous papillary carcinoma from endometrioid endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

Met, metastasis, motility and more

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

Tyrosine kinase mutations in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

The Met tyrosine kinase receptor in development and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

Hepatocyte growth factor (HGF) stimulates tumour invasiveness in papillary carcinoma of the thyroid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

Expression of the c-Met in advanced epithelial ovarian cancer and its prognostic significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

Hepatocyte growth factor (HGF) induces invasion of endometrial carcinoma cell lines in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

Hepatocyte growth factor (HGF) in ovarian epithelial tumour fluids stimulates the migration of ovarian carcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

An orally available small-molecule inhibitor of c-Met, PF-2341066, reduces tumor burden and metastasis in a preclinical model of ovarian cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.031

10.1016/J.YGYNO.2010.11.031

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21168200%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference